Zhongtong Bus received a letter of concern from the Shenzhen Stock Exchange after the "11-connection" response, saying that the sales of nucleic acid testing vehicles are currently low

On May 29, after receiving the letter of concern issued by the Shenzhen Stock Exchange, Zhongtong Bus, whose stock was awarded "11 consecutive boards", issued an announcement saying that the sales of nucleic acid testing medical vehicles that have recently attracted attention from the outside world are relatively small, which has a negative impact on the company's operating performance. No significant impact; in addition, the company has not found any undisclosed material information that may or has had a significant impact on the company's stock trading price recently reported by public media.

The content of the announcement shows that the closing price increase of Zhongtong Bus’s stock for three consecutive trading days on May 25, 26 and 27, 2022 deviates from the market value by more than 20%. According to relevant regulations, it is an abnormal fluctuation in stock trading.

(Source: Official Announcement)

Regarding recent media reports on the company's nucleic acid testing medical vehicles, Zhongtong Bus said that the company's products are mainly passenger cars, and the current sales of nucleic acid testing medical vehicles are relatively small, which has not had a significant impact on the company's operating performance.In addition to this, the company has not found any undisclosed material information recently reported by public media that may or have had a significant impact on the company's stock trading price.

Zhongtong Bus said that the information disclosed by the company in the early stage has no need to be corrected or supplemented; the company's recent production and operation conditions are normal, and the internal and external operating environment has not occurred and is not expected to undergo major changes; the company, controlling shareholders and actual controllers do not exist Regarding the company's major events that should be disclosed but not disclosed, there are no major events in the planning stage; the company, the controlling shareholder and the actual controller did not buy or sell the company's shares during the period of abnormal fluctuations in the company's stock transactions.

As of the close on May 30, the share price of Zhongtong Bus was 13.65 yuan, an increase of nearly 10%, and the 12th consecutive daily limit.

On May 27, Shenzhen Stock Exchange issued a letter of concern to Zhongtong Bus on the stock price change, requiring Zhongtong Bus to check whether the company's controlling shareholder, actual controller, directors, supervisors, senior managers and their immediate family members have any behavior of buying or selling the company's stock. , whether there is suspected insider trading.In response to the recent content related to the nucleic acid testing vehicle business of Zhongtong Bus on the interactive platform, the Shenzhen Stock Exchange requires the company to explain the company's nucleic acid testing vehicle business scale and the size of the company's nucleic acid testing vehicle based on the company's nucleic acid testing vehicleproduction, revenue, proportion, and orders in hand. The impact of the company's business development and profitability.In addition, Zhongtong Bus needs to analyze the composition of the company's main products from 2022 to the present, including but not limited to main products, models, production, sales, corresponding operating income and its proportion, etc., and explain whether the company has recently introduced any major products that have a significant impact on the company. industry policy.

Since May 13, Zhongtong Bus has achieved the daily limit for 12 consecutive trading days, and its stock price has risen from 4.4 yuan to 13.6 yuan, becoming the stock with the largest increase in May.In the face of the rising stock price, Zhongtong Bus has released 4 stock price change announcements in a row, saying that the company has not found any unpublished material information that may have a greater impact on the stock price, and there is no violation of fair disclosure of information.

In the context of the rebound of the epidemic, the surge in the share price of Zhongtong Bus may be related to nucleic acid testing equipment.On May 6, Zhongtong Bus released a news saying that the company delivered 18 nucleic acid testing vehicles at one time during the May Day holiday to help prevent and control the epidemic nationwide.On May 10, Zhongtong Bus once again issued a document that the nucleic acid detection vehicle developed and manufactured by the company has participated in the anti-epidemic work in many places across the country with the characteristics of flexibility, efficient detection, and safety protection.With the implementation of normalized nucleic acid testing measures in various places, equipment such as negative pressure ambulances and nucleic acid testing vehicles ushered in market opportunities.

Zhongtong Bus stated on the interactive platform that at present, the company's products sold in batches include two nucleic acid detection vehicles of 12 meters and 13 meters, all of which meet the P2+ biosafety laboratory standard, equipped with medical-specific air conditioning systems, equipped with high-efficiency fresh air filtration systems, medical Water supply and drainage system, automatic PCR analysis system, 5G signal transmission, etc., with the functions of on-the-fly sampling, on-demand inspection, and on-the-go reporting.

According to public information, Zhongtong Bus mainly focuses on passenger cars and takes into account the development, manufacture and sales of parts and components.The bus products cover different series and grades from 5 meters to 18 meters, and are mainly used for road, bus, tourism, group, school bus and other market segments.The company's business is based on orders and implements customized customization.In 2021, the company will complete the sales of 10,050 passenger cars.Among them, 3,001 light-duty buses were sold, an increase of 28.14%, 2,645 medium-duty buses were sold, a decrease of 36.06%, and 4,404 large buses were sold, an increase of 10.46%.

(Source: official website of the company)

Although the share price of Zhongtong Bus has soared, its financial performance is not optimistic.The financial report shows that in 2021, Zhongtong Bus achieved revenue of 4.587 billion yuan, a slight increase of 4.06% year-on-year; a loss of 220 million yuan, a decrease of 1033.23% compared with last year; in the first quarter of 2022, Zhongtong Bus achieved operating income of 863 million yuan in the quarter. , a year-on-year increase of 30.93%; net profit loss was 35.287 million yuan, a year-on-year decrease of 11.12%; non-net profit loss was 42.4648 million yuan, a year-on-year decrease of 38.31%.It is worth mentioning that since 2017, the net profit of Zhongtong Bus has been showing a downward trend.

Zhongtong Bus said that due to factors such as the new crown epidemic in 2021, the demand for the bus market will decline. According to the data of China Bus Information Statistics Network, the sales volume of the bus industry will drop by 7.8% year-on-year, and the competition will further intensify.The sluggish bus market in the company's major markets and the sharp contraction in demand from major overseas customers led to a decline in sales.At the same time, the price of raw materials has increased, the domestic industry competition has intensified, and the price war has intensified, resulting in a sharp drop in the company's profits.